Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Missouri

Peptide legality · Missouri · updated 2026-09-21

Are peptides legal in Missouri?

Gray area

Peptides sit in a legal gray zone in Missouri: the state has no peptide-specific law and defers to federal FDA rules, so FDA-approved GLP-1 medicines like Wegovy® (semaglutide) are legal by prescription while research peptides such as BPC-157 have no lawful path to human clinical use.

Legal status overview

Peptides sit in a legal gray zone in Missouri because the state has no peptide-specific statute and defers to federal FDA rules. Missouri regulates compounding through Chapter 338 RSMo and Title 20 CSR rules that incorporate the federal 503A and 503B compounding framework rather than naming peptides. FDA-approved GLP-1 medicines such as Ozempic® (semaglutide) and Zepbound® (tirzepatide) are legal when prescribed by an authorized provider, while unapproved research peptides like BPC-157 and TB-500 have no lawful pathway for human clinical use. Because status flows from federal drug law, the peptide's FDA standing, not a Missouri statute, decides whether it can be used.

Key points

  • Missouri has no statute, administrative rule, or Board of Pharmacy regulation that names peptides or research chemicals as a distinct category; only general compounding and licensure provisions apply. [4]
  • The Missouri Board of Pharmacy licenses and inspects compounding pharmacies under Chapter 338 RSMo and Title 20 CSR rules that incorporate the federal 503A and 503B compounding framework. [1]
  • Missouri's compounding standards of practice at 20 CSR 2220-2.400 govern sterile and non-sterile compounding and reference federal standards rather than establishing peptide-specific rules. [1]
  • FDA-approved GLP-1 medicines can be prescribed in Missouri by an MD, DO, a nurse practitioner with a collaborative practice arrangement, or a physician assistant with a supervising physician, so a valid prescriber relationship is required. [4]
  • Compounded semaglutide is not FDA-approved, is not a generic, and is not evaluated by the FDA; the FDA has stated compounders may no longer make GLP-1 copies now that the shortage is resolved and has issued warning letters to GLP-1 compounders. [5]
  • BPC-157 was placed in Category 2 of the FDA 503A bulk substances evaluation in 2023 and removed in April 2026, but removal is not Category 1 approval, so it still cannot be lawfully compounded for human use. [2]
  • FDA-approved growth hormone (somatropin) is legal only by physician prescription for approved indications; federal law prohibits distribution for anti-aging or bodybuilding. [4]

Compound-by-compound status

BPC-157
Gray area
Unapproved drug with no FDA-approved product and no completed federal rulemaking authorizing compounding, so not legal for human clinical use in Missouri. Available only through a research-use-only channel not intended for human use.
GLP-1 class (Wegovy® (semaglutide), Ozempic® (semaglutide), Zepbound® (tirzepatide), Mounjaro® (tirzepatide))
Legal By Prescription
Brand-name FDA-approved products are legal by prescription from an authorized Missouri prescriber. Compounded versions are not FDA-approved, are not a generic, and are not evaluated by the FDA, and are limited by the resolved-shortage federal policy.
TB-500 (thymosin beta-4 fragment)
Gray area
Unapproved drug with no FDA-approved product; not lawful for human clinical use in Missouri. Sold only as a research-use-only product not intended for human use.
Growth hormone / somatropin (e.g., Genotropin® (somatropin))
Legal By Prescription
FDA-approved somatropin is prescription-only for approved indications; federal law prohibits distribution for non-approved uses such as anti-aging or bodybuilding. No Missouri-specific peptide rule applies.

Frequently asked questions

Are peptides legal in Missouri?

Missouri has no peptide-specific law and defers to federal FDA rules. FDA-approved products like Wegovy® (semaglutide) are legal by prescription, while unapproved research peptides such as BPC-157 have no lawful clinical pathway. This is information, not legal or medical advice.

Who can prescribe GLP-1 medicines in Missouri?

An MD, DO, a nurse practitioner with a collaborative practice arrangement, or a physician assistant with a supervising physician can prescribe FDA-approved GLP-1 medicines when a valid prescriber relationship exists.

Can Missouri pharmacies still compound semaglutide?

Federal policy limits GLP-1 compounding now that the shortage is resolved, and the FDA has issued warning letters. Compounded semaglutide is not FDA-approved, is not a generic, and is not evaluated by the FDA.

Is BPC-157 legal to use clinically in Missouri?

No. BPC-157 is an unapproved drug with no FDA-approved product and no completed federal rulemaking authorizing compounding, so there is no lawful path for human clinical use.

Does Missouri regulate peptides differently from federal law?

No. Searches of Missouri statutes, rules, and newsletters find only general compounding and licensure provisions, so a peptide's federal FDA status effectively decides its legality.

General information based on the sourced research above, not legal advice. For a specific situation in Missouri, consult a licensed attorney familiar with pharmaceutical law.